» Authors » Valeria Tarallo

Valeria Tarallo

Explore the profile of Valeria Tarallo including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 32
Citations 1566
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Tarallo V, Magliacane Trotta S, Panico S, DOrsi L, Mercadante G, Cicatiello V, et al.
Invest Ophthalmol Vis Sci . 2024 Jul; 65(8):12. PMID: 38967942
Purpose: Recruitment and activation of inflammatory cells, such as retinal microglia/macrophages, in the subretinal space contribute significantly to the pathogenesis of age-related macular degeneration (AMD). This study aims to explore...
2.
Magliacane Trotta S, Adinolfi A, DOrsi L, Panico S, Mercadante G, Mehlen P, et al.
Exp Mol Med . 2024 Mar; 56(3):700-710. PMID: 38486106
Inflammation plays a crucial role in cancer progression, but the relevance of the inflammasome remains unclear. Alu RNA was the first endogenous nucleic acid shown to activate the NLRP3 (nucleotide-binding...
3.
Santonocito M, Zappulla C, Viola S, La Rosa L, Solfato E, Abbate I, et al.
Int J Mol Sci . 2021 Apr; 22(9). PMID: 33922399
Eye drop formulations allowing topical treatment of retinal pathologies have long been sought as alternatives to intravitreal administration. This study aimed to assess whether a novel nanostructured microemulsions system (NaMESys)...
4.
Pignata P, Apicella I, Cicatiello V, Puglisi C, Magliacane Trotta S, Sanges R, et al.
Int J Mol Sci . 2021 Apr; 22(8). PMID: 33918807
Prolyl 3-hydroxylase 2 () catalyzes the post-translational formation of 3-hydroxyproline on collagens, mainly on type IV. Its activity has never been directly associated to angiogenesis. Here, we identified gene through...
5.
Marrocco E, Indrieri A, Esposito F, Tarallo V, Carboncino A, Alvino F, et al.
Sci Rep . 2020 Jun; 10(1):9619. PMID: 32541823
The presence of α-synuclein aggregates in the retina of Parkinson's disease patients has been associated with vision impairment. In this study we sought to determine the effects of α-synuclein overexpression...
6.
Tarallo V, Iaccarino E, Cicatiello V, Sanna R, Ruvo M, De Falco S
Int J Mol Sci . 2020 Jan; 21(2). PMID: 31936463
Age-related macular degeneration (AMD) is the primary cause of blindness in advanced countries. Repeated intravitreal delivery of anti-vascular endothelial growth factor (VEGF) agents has represented an important advancement for the...
7.
Lazzara F, Fidilio A, Platania C, Giurdanella G, Salomone S, Leggio G, et al.
Biochem Pharmacol . 2019 Jul; 168:341-351. PMID: 31351870
Diabetic retinopathy (DR) is a secondary complication of diabetes. DR can cause irreversible blindness, and its pathogenesis is considered multifactorial. DR can progress from non-proliferative DR to proliferative DR, characterized...
8.
Apicella I, Cicatiello V, Acampora D, Tarallo V, De Falco S
Cell Rep . 2018 Jun; 23(12):3635-3646. PMID: 29925004
Placental growth factor (PlGF) is a proangiogenic member of the vascular endothelial growth factor (VEGF) family playing a central role in pathological angiogenesis. PlGF-DE is a PlGF variant unable to...
9.
Tudisco L, Orlandi A, Tarallo V, De Falco S
Oncotarget . 2017 Apr; 8(20):32873-32883. PMID: 28427198
Placental growth factor (PlGF), a proangiogenic member of vascular endothelial growth family, is active during pathological conditions like cancer, metastasis formation and hind limb ischemia and in wound healing. Endothelial...
10.
Yasuma R, Cicatiello V, Mizutani T, Tudisco L, Kim Y, Tarallo V, et al.
Signal Transduct Target Ther . 2016 Mar; 1. PMID: 26925256
Human intravenous immune globulin (IVIg), a purified IgG fraction composed of ~ 60% IgG1 and obtained from the pooled plasma of thousands of donors, is clinically used for a wide...